Form 8-K - Current report:
SEC Accession No. 0001104659-21-013630
Filing Date
2021-02-08
Accepted
2021-02-08 14:30:20
Documents
15
Period of Report
2021-02-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm215748d1_8k.htm   iXBRL 8-K 25379
2 EXHIBIT 99.1 tm215748d1_ex99-1.htm EX-99.1 19701
3 EXHIBIT 99.2 tm215748d1_ex99-2.htm EX-99.2 18197
7 GRAPHIC tm215748d1ex99-2img001.jpg GRAPHIC 4999
  Complete submission text file 0001104659-21-013630.txt   255979

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fold-20210208.xsd EX-101.SCH 3217
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20210208_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20210208_pre.xml EX-101.PRE 22731
8 EXTRACTED XBRL INSTANCE DOCUMENT tm215748d1_8k_htm.xml XML 3486
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 21600863
SIC: 2834 Pharmaceutical Preparations